MRKWatch

Merck & Co

$131.82

Community outlook

Bullish54%

Questions Discussion Earnings Data & analysis

Next report

Tue, 4 Aug 2026

in 6 daysbefore market open

EPS estimate

$-0.28

Wall Street consensus

Revenue estimate

$16.5B

Wall Street consensus

Expected swing

±3.6%

±1σ by report day, from realized volatility

Also reporting that week:AMD CAT MCD PFE SPOT DIS LLY MELI

EPS outlook

Odds turned into a number: where the print lands if MRK's usual surprise repeats — and what the crowd's beat odds imply on the same scale.

Street estimate

$•.••

the bar to clear

If history repeats

$•.••

•• of •• quarters beat

Crowd implies

—

needs more forecasts on the beat question

Typical range for the print: $•.•• – $•.••±1σ of past surprises
Beat odds implied by the record: ••%ceiling on •• quarters

A beat probability is a statement about where the print sits relative to the estimate. Scaled by how far recent quarters landed from the Street, it becomes a dollar figure. Not a forecast of the stock — companies fall on beats.

The crowd's read

Live odds from the community — tap through to make your own call.

Will Merck & Co be higher in 3 months than today?

Nearest crowd call that settles after the report · 6 forecasting

61%

Forecast

The Street's stance

Analyst consensus — and whether it has been improving or souring into the print.

Buy

36 analysts · 25 buy · 11 hold · 0 sell

steady over the last 3 months

Estimate track record

Reported EPS against the Street's estimate, most recent first — the same feed our earnings questions settle on.

Beat rate

4 of 4

quarters beat the estimate

Avg surprise

+9.9%

vs EPS estimate

Quarter	Estimate	Actual	Surprise	Result
Mar 2026	$-1.52	$-1.28	+16.0%	BEAT
Dec 2025	$2.03	$2.09	+3.0%	BEAT
Sept 2025	$2.37

Fundamentals snapshot

Trailing-twelve-month figures for context around the print.

Market cap

$331.6B

EPS (TTM)

$3.55

P/E (TTM)

37.1

price ÷ trailing earnings

Revenue growth

+2.9%

TTM vs a year ago

Gross margin

78.1%

of revenue kept after costs

Net margin

13.6%

of revenue kept as profit

52-week range

$77 – $135

now $131.82

Beta

0.21

steadier than the market

Dividend yield

2.48%

Estimates and reported figures via Finnhub; crowd odds are Merck & Co forecasts on Probs. Information, not investment advice.